- $421.10m
- $420.55m
- $126.08m
- 71
- 34
- 70
- 60
Annual balance sheet for SurModics, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 61.1 | 38.9 | 19 | 45.4 | 40.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 16.2 | 22.9 | 24.2 | 23.9 | 23.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 86.6 | 70.3 | 57.6 | 86.7 | 81.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 32.6 | 32.5 | 30.8 | 29 | 28 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 169 | 195 | 158 | 186 | 179 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.9 | 29.8 | 32.1 | 24 | 20.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 37.7 | 54.5 | 50 | 65.8 | 59.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 131 | 140 | 108 | 120 | 119 |
Total Liabilities & Shareholders' Equity | 169 | 195 | 158 | 186 | 179 |
Total Common Shares Outstanding |